The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

C•••••••

Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Also written as: Kure Pain Holdings, Inc
See every lender's markFind rescue capital
More
Special situations PE firms

Nothing material in the last 200 days. No dated change on record yet.

Mark path, consensus per quarter end
Q3 2025: 101¢Q4 2025: 102¢Q1 2026: 101¢Q2 2026: 101¢101¢ · 102¢ · 101¢ · 101¢Q3 2025 to Q2 2026
Principal held
at least $622,939
sum of BDC pieces, a lower bound
Fair value
$615,932
101c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
2
1 on the latest quarter
Facilities
3
0 equity pieces beside them
Next maturity
Aug 30, 2030
no dated debt inside 24 months
On the tape since
Mar 31, 2022
latest Jun 30, 2026
Events
1
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
LenderExposureCurrent markQoQ change
A•••• C••••• B•• I•••$623K101¢0 pts
Every BDC piece · 8 positions across 1 lenderlargest principal first, with instrument and rate
BDCInstrumentPrincipalFair valueRate
A•••• C••••• B•• I•••term loan first lien
Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 5.50% I••••••• R••• 9.23% A••••••••• D•
$405,029$400,473
100c
SOFR+550 bp
A•••• C••••• B•• I•••term loan first lien
Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 5.50% I••••••• R••• 9.23% A••••••••• D•
$147,672$146,011
101c
SOFR+550 bp
A•••• C••••• B•• I•••revolver first lien
Investment T••• 1st L••• R••••••• I•••• S+ S••••• 5.50% I••••••• R••• 9.23% A••••••••• D••
$38,067$37,639
107c
SOFR+550 bp
A•••• C••••• B•• I•••term loan first lien
Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 5.50% I••••••• R••• 9.23% A••••••••• D•
$16,722$16,534
100c
SOFR+550 bp
A•••• C••••• B•• I•••term loan first lien
Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 5.50% I••••••• R••• 9.23% A••••••••• D•
$11,257$11,131
100c
SOFR+550 bp
View all 8 positionslargest principal first
BDCInstrumentPrincipalFair valueRate
A•••• C••••• B•• I•••term loan first lien
Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 4.50% I••••••• R••• 9.23% A••••••••• D•
$4,192$4,144
100c
SOFR+550 bp
A•••• C••••• B•• I•••delayed draw term loan first lien
Investment T••• S••••• S•••••• T•••• A•••••••• D•••••• D••• L••• I•••• S+ S••••• 5.50% I••
Not disclosedNot disclosedSOFR+550 bp
A•••• C••••• B•• I•••revolver first lien
Investment T••• S••••• S•••••• R•••••••• L••• I•••• S+ S••••• 5.50% I••••••• R••• 9.18% M•
Not disclosedNot disclosedSOFR+550 bp
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lienat least $584,872100cSOFR+550 bpAug 30, 20301
first lien revolver first lienat least $38,067n/aSOFR+550 bpAug 30, 20301
first lien delayed draw term loan first lienunknownn/aSOFR+550 bpAug 30, 20301
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20261$622,939$615,932101c0
Mar 31, 20261$608,382$603,821101c0
Dec 31, 20251$609,828$606,779102c0
Sep 30, 20251$544,553$536,387101c0
All 5 quarters
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Dec 31, 20241$0$0n/a0
What changed
Every change including routine ones
Identity
Group key
CLEARWAYderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 2 BDCsderived
Industry
Healthcare & Pharmaceuticalsreportedas one filer wrote it